Treatment of Autoimmune Disorders (2003. 200 p. w. 50 figs.)

個数:

Treatment of Autoimmune Disorders (2003. 200 p. w. 50 figs.)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 200 p.
  • 商品コード 9783211837726

基本説明

It includes neurological, gastrointestinal, ophthalmological and skin diseases as well as current and future therapeutic options including immunomodulatory drugs and different vaccination strategies.

Full Description

Progress in basic and clinical immunology within the last two decades has provided profound insight into the immune system and its role in preventing endogenous and exogenous damage. In contrast, disbalances within this system can result in autoimmune disorders which may affect diverse organs and result in distinct clinical pictures. In many of these, however, the individual etiopathogenetic mechanisms are poorly understood and even more their clinical symptoms are hard to treat.
The book offers insight into basic mechanisms of autoimmune disorders. It includes neurological, gastrointestinal, ophthalmological and skin diseases as well as current and future therapeutic options including immunomodulatory drugs and different vaccination strategies. By addressing diverse organ systems, both singular and shared features are elaborated. Thus an exchange of ideas is intended across research on single organ systems within a truly interdisciplinary setting.

Contents

Foreword (K. M. Richter) Preface (M. Sticherling, E. Christophers) Definitive T cell epitope mapping for a human disease: gluten challenge in coeliac disease identifies a dominant transglutaminase-deamidated T cell epitope (Robert P. Anderson) On the extrapolation from animal models to human disease for the design of immunotherapy in autoimmune diabetes (Jean-F. Bach) Use of olfactory ensheathing cells as candidates for transplant-mediated repair of central nervous system lesions (Susan C. Barnett) Advances in understanding and use of autoantibodies as markers of diseases (Marvin J. Fritzler, Leeanne J. Schoenroth) Leflunomide therapy for autoimmune diseases (Angela Gause, Claudia Metzler, Eva Reinhold-Keller, Wolfgang L. Gross) Immunotherapy for ocular inflammatory disease (Kathrin H. Greiner, John V. Forrester) Advances in immunosuppressive treatment of juvenile idiopathic arthritis (Gerd Horneff) Significance of gamma-delta T lymphocytes in autoimmune diseases (Dieter Kabelitz) Treatment of autoimmune diseases by targeted DNA vaccines encoding proinflammatory mediators (Nathan Karin) Immunosuppressive treatment of rheumatic diseases during pregnancy (Monika Østensen) Persistence of maternal and fetal cells in autoimmune diseases (Anne M. Stevens, J. Lee Nelson, Nathalie Lambert) Therapeutic aspects of autoimmune diseases of the skin (Michael Sticherling) Long-term effects of T cell vaccination in multiple sclerosis (Piet Stinissen, Guy Hermans, Niels Hellings, Robert Medaer, Jef Raus) Plasmid-mediated delivery of antigens or biological response modifiers as means to suppress autoimmunity (Matthias von Herrath, Adrian Bot) Intravenous immunoglobulins for the treatment of childhood autoimmune diseases (Volker Wahn)